Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Shigella vaccines.

S B Formal1, T L Hale, C Kapfer

  • 1Department of Enteric Infections, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100.

Reviews of Infectious Diseases
|May 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection.

Vaccine·2011
Same author

Ultrasound measured renal length versus low dose CT volume in predicting single kidney glomerular filtration rate.

The British journal of radiology·2004
Same author

Molecular analysis of the stylar-expressed Solanum chacoense small asparagine-rich protein family related to the HT modifier of gametophytic self-incompatibility in Nicotiana.

The Plant journal : for cell and molecular biology·2002
Same author

Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.

Infection and immunity·2001
Same author

Novel self-sampling culture method to monitor excretion of live, oral Shigella flexneri 2a vaccine SC602 during a community-based phase 1 trial.

The Journal of laboratory and clinical medicine·1999
Same author

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.

Infection and immunity·1999
Same journal

Fatal necrotizing otitis externa in a patient with AIDS.

Reviews of infectious diseases·1991
Same journal

Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces.

Reviews of infectious diseases·1991
Same journal

A new case of meningitis due to Pasteurella multocida.

Reviews of infectious diseases·1991
Same journal

Disseminated pelvic actinomycosis presenting as metastatic carcinoma: association with the progestasert intrauterine device.

Reviews of infectious diseases·1991
Same journal

Genetically engineered attenuated herpes simplex viruses.

Reviews of infectious diseases·1991
Same journal

Role of altered drug metabolism in virus-drug interactions.

Reviews of infectious diseases·1991
See all related articles

Shigellosis is a significant health issue, particularly for children in developing nations. Understanding Shigella genetics is key to developing effective oral vaccines to combat this invasive colonic mucosa infection.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Vaccinology

Background:

  • Shigellosis is a major public health concern, predominantly affecting young children in developing countries.
  • The disease is caused by Shigella, an organism that invades the colonic mucosa.
  • Shigella shares genetic similarities with nonpathogenic Escherichia coli, with potential for gene transfer influencing virulence.

Purpose of the Study:

  • To explore the genetic basis of Shigella virulence.
  • To identify targets for vaccine development against shigellosis.
  • To assess the potential for genetic exchange between Shigella and E. coli.

Main Methods:

  • Analysis of Shigella genetics and virulence factors.
  • Investigation of genetic material transfer mechanisms between Shigella and E. coli.

Related Experiment Videos

  • Research into the construction of attenuated oral vaccines.

    • Main Results:

    • Genetic exchange between Shigella and E. coli can alter the pathogenicity of E. coli or the virulence of Shigella strains.
    • Knowledge of Shigella virulence genetics is crucial for vaccine design.

    Conclusions:

    • Understanding Shigella genetics is essential for controlling shigellosis.
    • Living, attenuated oral vaccines offer a practical approach to disease control.